Twist Bioscience to Present at Upcoming Investor Conferences

Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST), a biotechnology company specializing in synthetic DNA, has announced its executives' participation in several upcoming investor conferences. Patrick Finn, Ph.D., president and COO, will join a fireside chat at the Leerink Partners Healthcare Crossroads Conference on May 29 in Austin, TX. Emily Leproust, Ph.D., CEO and co-founder, will present at the William Blair Growth Stock Conference on June 4 in Chicago, IL, at the Jefferies Global Healthcare Conference on June 6 in New York, NY, and will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11 in Miami, FL. The sessions will be webcast live and available on the company's website, with replays accessible for 30 days after the events.

Positive

• Executives' participation in multiple high-profile investor conferences.
• Webcast availability of presentations and fireside chats for broader investor access.
• Increased visibility among investors may attract new investments and partnerships.

Negative

• No new financial data or clinical results announced in the press release.
• Potential shareholder dilution concerns if new investments require equity offerings.
• Operational costs associated with attending multiple conferences.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that its executives will present and participate in fireside chats at the following upcoming investor conferences:

• Patrick Finn, Ph.D., president and COO, will participate in a fireside chat at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, in Austin, TX; fireside chat at 2:20 p.m. Central Time
• Emily Leproust, Ph.D., CEO and co-founder, will present at the William Blair Growth Stock Conference on Tuesday, June 4 in Chicago, IL; presentation at 2:40 p.m. Central Time
• Emily Leproust, Ph.D., CEO and co-founder, will present at the Jefferies Global Healthcare Conference on Thursday, June 6 in New York, NY; presentation at 8:30 a.m. Eastern Time
• Emily Leproust, Ph.D., CEO and co-founder, will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11 in Miami, FL; fireside chat at 10:00 a.m. Eastern Time

The fireside chats and presentations will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chats and presentations will be archived for a period of 30 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on LinkedIn | X | YouTube | Instagram

View source version on businesswire.com: https://www.businesswire.com/news/home/20240523995309/en/

For Investors:

Angela Bitting

SVP, Corporate Affairs

925-202-6211

abitting@twistbioscience.com

For Media:

Amanda Houlihan

Communications Manager

774-265-5334

ahoulihan@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

When will Twist Bioscience executives participate in the Leerink Partners Healthcare Crossroads Conference?

Patrick Finn, Ph.D., president and COO of Twist Bioscience, will participate in a fireside chat on May 29 at 2:20 p.m. Central Time.

What time is the Twist Bioscience presentation at the William Blair Growth Stock Conference?

Emily Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present on June 4 at 2:40 p.m. Central Time.

When is Twist Bioscience scheduled to present at the Jefferies Global Healthcare Conference?

Emily Leproust, Ph.D., will present on June 6 at 8:30 a.m. Eastern Time.

How can I access the Twist Bioscience investor conference presentations?

The presentations and fireside chats will be webcast live and can be accessed via the 'Investor Calendar' page on Twist Bioscience's website.

How long will replays of the Twist Bioscience presentations be available?

Replays will be archived and available for 30 days following the conclusion of the live events.